Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.
Mulholland M, Depuydt MAC, Jakobsson G, Ljungcrantz I, Grentzmann A, To F, Bengtsson E, Jaensson Gyllenbäck E, Grönberg C, Rattik S, Liberg D, Schiopu A, Björkbacka H, Kuiper J, Bot I, Slütter B, Engelbertsen D.
Mulholland M, et al. Among authors: gronberg c.
Cardiovasc Res. 2024 May 7;120(6):581-595. doi: 10.1093/cvr/cvae046.
Cardiovasc Res. 2024.
PMID: 38563353
Free PMC article.